ATE82503T1 - Anorganische mineralzusammensetzung. - Google Patents
Anorganische mineralzusammensetzung.Info
- Publication number
- ATE82503T1 ATE82503T1 AT86301421T AT86301421T ATE82503T1 AT E82503 T1 ATE82503 T1 AT E82503T1 AT 86301421 T AT86301421 T AT 86301421T AT 86301421 T AT86301421 T AT 86301421T AT E82503 T1 ATE82503 T1 AT E82503T1
- Authority
- AT
- Austria
- Prior art keywords
- parts
- mixture
- zinc
- calcium
- balance
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 229910052500 inorganic mineral Inorganic materials 0.000 title 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 abstract 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 abstract 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 abstract 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 abstract 2
- 235000011130 ammonium sulphate Nutrition 0.000 abstract 2
- 239000011575 calcium Substances 0.000 abstract 2
- 229910052791 calcium Inorganic materials 0.000 abstract 2
- 229910052802 copper Inorganic materials 0.000 abstract 2
- 239000010949 copper Substances 0.000 abstract 2
- WMWXXXSCZVGQAR-UHFFFAOYSA-N dialuminum;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3] WMWXXXSCZVGQAR-UHFFFAOYSA-N 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 239000000395 magnesium oxide Substances 0.000 abstract 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 abstract 2
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000377 silicon dioxide Substances 0.000 abstract 2
- 235000012239 silicon dioxide Nutrition 0.000 abstract 2
- 239000011701 zinc Substances 0.000 abstract 2
- 229910052725 zinc Inorganic materials 0.000 abstract 2
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/822,532 US4810496A (en) | 1985-02-19 | 1986-01-27 | Treatment of skin and inflammatory disorders |
| EP86301421A EP0235417B1 (de) | 1986-01-27 | 1986-02-27 | Anorganische Mineralzusammensetzung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE82503T1 true ATE82503T1 (de) | 1992-12-15 |
Family
ID=25236296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86301421T ATE82503T1 (de) | 1986-01-27 | 1986-02-27 | Anorganische mineralzusammensetzung. |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4810496A (de) |
| EP (1) | EP0235417B1 (de) |
| AT (1) | ATE82503T1 (de) |
| CA (1) | CA1270196A (de) |
| DE (1) | DE3687145D1 (de) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX168552B (es) * | 1985-02-19 | 1993-05-31 | Jensen Charles A | Procedimiento para la preparacion de polvo mineral inorganico |
| US4931274A (en) * | 1986-02-27 | 1990-06-05 | Physiological Research Associates | Composition for the effective treatment of scalp diseases that delivers magnesium adsorbed in alumina silicate clays to affected sites |
| US5061724A (en) * | 1989-07-18 | 1991-10-29 | Sheldon Gertner | Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis |
| US5435997A (en) * | 1994-02-08 | 1995-07-25 | Burns; Michael J. | Topical agent and method for the treatment of pseudofolliculitis barbae |
| US5503822A (en) * | 1994-04-01 | 1996-04-02 | Schulman; Jerome M. | Medicated gel |
| US5516517A (en) * | 1994-05-02 | 1996-05-14 | Exfoliation Cleansing Hydration Oxygenation Corporation | Method for nutritional oxygenation of the skin |
| US5667790A (en) * | 1995-08-14 | 1997-09-16 | Sellers, Jr.; Billy B. | Aluminum chlorhydrate as a treatment for acne and rosacea |
| US6565893B1 (en) | 1999-02-17 | 2003-05-20 | Worldwide Pure Water, Inc. | Process for preparing a disinfectant containing suspended metals |
| US20030072814A1 (en) * | 1999-12-16 | 2003-04-17 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of warts |
| US20030077301A1 (en) * | 1999-12-16 | 2003-04-24 | Maibach Howard I. | Topical pharmaceutical composition for the treatment of inflammatory dermatoses |
| EP1129715A1 (de) * | 2000-02-25 | 2001-09-05 | Werner Dr. Reichen | Anwendung von Magnesium, Kalzium und Silizium zur Heilung verschiedener Krankheiten und zum allgemeinen Wohlbefinden |
| GB0202017D0 (en) * | 2002-01-29 | 2002-03-13 | Unilever Plc | Detergent compositions |
| GB0228354D0 (en) * | 2002-12-05 | 2003-01-08 | Unilever Plc | Detergent compositions |
| WO2003064582A1 (en) * | 2002-01-29 | 2003-08-07 | Unilever Plc | Detergent compositions |
| US6846837B2 (en) * | 2002-06-21 | 2005-01-25 | Howard I. Maibach | Topical administration of basic antifungal compositions to treat fungal infections of the nails |
| US6943197B2 (en) * | 2002-06-21 | 2005-09-13 | Howard I. Maibach | Topical administration of pharmacologically active bases in the treatment of inflammatory dermatoses |
| US6821523B2 (en) * | 2002-06-21 | 2004-11-23 | Dermatrends, Inc. | Topical administration of pharmacologically active bases in the treatment of warts |
| KR20040031361A (ko) * | 2002-10-04 | 2004-04-13 | 김고정 | 세포활성 및 독성제거제 |
| US20040091417A1 (en) * | 2002-11-07 | 2004-05-13 | Nanoproducts Corporation | Nanotechnology for agriculture, horticulture, and pet care |
| US7611732B2 (en) * | 2004-07-26 | 2009-11-03 | Michael Bentley | Nutritional supplement for osteoarthritis |
| EP1627641A1 (de) * | 2004-08-04 | 2006-02-22 | Victor Eluwa | Metalloxide enthaltende pharmazeutische Zusammensetzungen und deren Anwendungen |
| US7943617B2 (en) * | 2006-11-27 | 2011-05-17 | Bristol-Myers Squibb Company | Heterobicyclic compounds useful as kinase inhibitors |
| GB0805279D0 (en) * | 2008-03-20 | 2008-04-30 | Univ Nottingham Trent | Food supplement |
| FR2931359B1 (fr) * | 2008-05-20 | 2012-12-21 | Menvielle Bourg Fabienne Joanny | Utilisation d'une matrice pour administration orale de magnesium a liberation prolongee, et composition contenant cette matrice |
| FR2931361B1 (fr) * | 2008-05-20 | 2012-08-31 | Menvielle Bourg Fabienne Joanny | Systeme a base de magnesium et son utilisation en cosmetique |
| US20140234394A1 (en) * | 2013-02-19 | 2014-08-21 | William A. McDonough | Benefical contact surfaces for functional objects |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3137622A (en) * | 1957-12-23 | 1964-06-16 | Kline | Topical therapeutic composition |
| FR2336938A1 (fr) * | 1976-01-02 | 1977-07-29 | Sato Masataro | Medicament a base de montmorillonite |
| JPS57156419A (en) * | 1981-03-24 | 1982-09-27 | Kyowa Chem Ind Co Ltd | Remedy for sideropenia |
-
1986
- 1986-01-27 US US06/822,532 patent/US4810496A/en not_active Expired - Fee Related
- 1986-02-06 CA CA000501257A patent/CA1270196A/en not_active Expired
- 1986-02-27 AT AT86301421T patent/ATE82503T1/de not_active IP Right Cessation
- 1986-02-27 EP EP86301421A patent/EP0235417B1/de not_active Expired
- 1986-02-27 DE DE8686301421T patent/DE3687145D1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4810496A (en) | 1989-03-07 |
| EP0235417B1 (de) | 1992-11-19 |
| CA1270196A (en) | 1990-06-12 |
| EP0235417A1 (de) | 1987-09-09 |
| DE3687145D1 (de) | 1992-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3687145D1 (de) | Anorganische mineralzusammensetzung. | |
| IL76119A (en) | Device for initiating reperfusion treatment when heart attack symptoms are present | |
| GR880300077T1 (en) | Galanthamine or analogues thereof for treating alzheimer's disease | |
| EP0363415A4 (en) | Compounds for the treatment of alzheimer's disease | |
| JPS6480260A (en) | Iron-calcium mineral supplied product having high biological utility | |
| SE8801454D0 (sv) | Sele for en livlina | |
| IL89175A (en) | Ultrasonic contrast agents and processes for the preparation thereof | |
| GB8604528D0 (en) | Therapeutic agents | |
| IL89807A (en) | Topical preparation containing ofloxacin for treating otopathy | |
| PT86205A (en) | Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy | |
| EP0285856A3 (en) | Use of dihydroergotamine and its salts in the local treatment of trophic disorders | |
| GB2156345B (en) | Alkylamine salts of 3,5-diacetylamino-2,4,6-triiodobenzoic acid as x-ray contrast agents | |
| ZA904671B (en) | Hair treatment composition | |
| GB8823605D0 (en) | Therapeutic agents | |
| FI850613L (fi) | Isoxazolderivat, foerfarande foer framstaellning av dessa samt dessa foereningar innehaollande laekemedel. | |
| JPS6481886A (en) | Hydrous soil solidifying agent | |
| PT81933A (en) | Process for preparing improved antiinflammatory compositions containing pyroxicam and inositol | |
| EP0199888A3 (en) | Control of heme and iron concentrations in body tissues | |
| NZ220495A (en) | A2a cyclopeptan-2-ones carrier containing methotrexate compositions | |
| GB8713169D0 (en) | Uptake of iron by body | |
| GR3001746T3 (en) | Method of regulating animal reproduction | |
| Menninger | The middle of the journey: Dragons and grails. | |
| NZ220242A (en) | Regulating fertility in cattle by administering epostane | |
| HUT41632A (en) | Process for preparing agents for the enhancement of protein absorption | |
| EP0151245A3 (en) | Soporific comprising lorazepam |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |